Patents-Review.com
ClassID:

20024 ⎘

A61K9/0029 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner Parenteral nutrition; Parenteral nutrition compositions as drug carriers

Recent Application in this class:
#1
20260152732
2026-06-04

ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY

 #2
20260125373
2026-05-07

Pharmaceutical Formulations and Methods for the Treatment of Gastrointestinal Disorders

 #3
20260124186
2026-05-07

Nimodipine Parenteral Administration

 #4
20260102386
2026-04-16

USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS

 #5
20260090983
2026-04-02

PARENTERAL NUTRITION FORMULATION

 #6
20260053745
2026-02-26

METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES

 #7
20250388549
2025-12-25

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

 #8
20250388548
2025-12-25

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

 #9
20250388547
2025-12-25

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

 #10
20250388546
2025-12-25

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

 #11
20250388545
2025-12-25

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

 #12
20250376448
2025-12-11

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

 #13
20250376447
2025-12-11

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

 #14
20250332206
2025-10-30

PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTIC AND PREBIOTIC TO TREAT STUNTING

 #15
20250332092
2025-10-30

LIQUID COMPOSITION COMPRISING GLUCOSE

 #16
20250282843
2025-09-11

COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT

 #17
20250262169
2025-08-21

METHODS OF TREATING COENZYME Q10 DEFICIENCY

 #18
20250248964
2025-08-07

Long-term efficacy of liver disease treatment with EPA and DHA

 #19
20250223287
2025-07-10

PHARMACEUTICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

 #20
20250179011
2025-06-05

IMPROVED METHOD OF SYNTHESIS AND PURIFICATION OF CITRULLINE

 #21
20250144314
2025-05-08

VITAMIN K1 INJECTION DEVICE KIT

 #22
20250136670
2025-05-01

Monoclonal Antibodies Against Alpha-Synuclein Fibrils

 #23
20250134810
2025-05-01

LIPID PARTICLES, METHODS OF GENERATING SAME, AND METHODS OF USING SAME

 #24
20250134779
2025-05-01

METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS

 #25
20250127860
2025-04-24

SEMAGLUTIDE DEPOT SYSTEMS AND USE THEREOF

 #26
20250114406
2025-04-10

METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM BLOOD PRODUCTS

 #27
20250082676
2025-03-13

TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE

 #28
20250082675
2025-03-13

TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE

 #29
20250059276
2025-02-20

ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF

 #30
20250057757
2025-02-20

Compositions for providing parenteral nutrition to pediatric patients

 #31
20250041206
2025-02-06

Injectable Suspensions

 #32
20250031737
2025-01-30

DEVICES AND METHODS FOR THE PREPARATION OF A NUTRITIONAL FORMULA

 #33
20250009699
2025-01-09

LIPID EMULSIONS FOR PARENTERAL NUTRITION

 #34
20240415945
2024-12-19

C1-ESTERASE INHIBITOR PREPARATION

 #35
20240409558
2024-12-12

IRREVERSIBLE INHIBITORS OF KRAS

 #36
20240390427
2024-11-28

METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM CULTURED CELLS

 #37
20240382414
2024-11-21

LIPID EMULSION FOR PARENTERAL NUTRITION COMPRISING GPC

 #38
20240368116
2024-11-07

IMMUNOREGULATORY COMPOUNDS

 #39
20240350370
2024-10-24

METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS

 #40
20240350369
2024-10-24

METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS

 #41
20240316096
2024-09-26

Trace element compositions, methods of making and use

 #42
20240307298
2024-09-19

PROCESS FOR MANUFACTURING AN OIL-AN-WATER EMULSION WITH A LOW PFAT5 VALUE IN ADMIXTURES FOR PARENTERAL NUTRITION

 #43
20240299447
2024-09-12

Trace element compositions, methods of making and use

 #44
20240277607
2024-08-22

PARENTERAL NUTRITION CONTAINING TRACE ELEMENTS

 #45
20240271116
2024-08-15

SUPPRESSION OF PAIN BY GENE EDITING

 #46
20240226143
2024-07-11

PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES COMPRISING GERMANIUM TELLURIDE NANOSHEETS COATED WITH POLYVINYLPYRROLIDONE

 #47
20240197884
2024-06-20

COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY

 #48
20240191218
2024-06-13

ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY

 #49
20240166709
2024-05-23

ANALOGUES OF PYY

 #50
20240131057
2024-04-25

PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES COMPRISING GERMANIUM TELLURIDE NANOSHEETS COATED WITH POLYVINYLPYRROLIDONE

 #51
20240109844
2024-04-04

CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

 #52
20240099965
2024-03-28

OXYTOCIN READY TO INFUSE DOSAGE FORM

 #53
20240082373
2024-03-14

COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY AND USES THEREOF

 #54
20240065943
2024-02-29

Methods, compositions, and devices for supplying dietary fatty acid needs

 #55
20240058378
2024-02-22

Trace element compositions, methods of making and use

 #56
20240042092
2024-02-08

POLYMER PARTICLES

 #57
20230373990
2023-11-23

Pharmaceutical formulations for the treatment of gastrointestinal disorders

 #58
20230372500
2023-11-23

Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

 #59
20230364116
2023-11-16

PARENTERAL NUTRITION FORMULATION AND METHODS OF PREPARATION THEREOF

 #60
20230364106
2023-11-16

PARENTERAL DOSAGE FORM OF DILTIAZEM

 #61
20230364068
2023-11-16

Nimodipine Parenteral Administration

 #62
20230355547
2023-11-09

STABILIZATION OF VITAMIN A IN A NUTRITIONAL SOLUTION

 #63
20230339933
2023-10-26

Methods for the treatment of gastro-intestinal disorders

 #64
20230338481
2023-10-26

DIGESTIVE ENZYME COMPOSITION SUITABLE FOR ENTERAL ADMINISTRATION

 #65
20230310353
2023-10-05

3-HYDROXYBUTYRATE ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF CRITICAL CARE TREATMENT

 #66
20230302047
2023-09-28

Trace element compositions, methods of making and use

 #67
20230293458
2023-09-21

MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME

 #68
20230263858
2023-08-24

NUTRITION FORMULATION

 #69
20230212227
2023-07-06

PHARMACEUTICAL PARENTERAL COMPOSITION OF DUAL GLP1/2 AGONIST

 #70
20230192868
2023-06-22

ANTI-IGF-I RECEPTOR ANTIBODY

 #71
20230192648
2023-06-22

Aromatic immunoregulatory compounds for treatment of inflammatory diseases

 #72
20230149484
2023-05-18

PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTIC AND PREBIOTIC TO TREAT STUNTING

 #73
20230135144
2023-05-04

Stable ready-to-use carmustine pharmaceutical composition

 #74
20230126347
2023-04-27

Analogues of PYY

 #75
20230114648
2023-04-13

Tannin-containing gastrointestinal formulations and methods of use

 #76
20230111947
2023-04-13

METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES

 #77
20230080524
2023-03-16

Pharmaceutical composition for treating inflammatory diseases comprising germanium telluride nanosheets coated with polyvinylpyrrolidone

 #78
20230054162
2023-02-23

METHODS FOR PRODUCING OIL-IN-WATER EMULSIONS

 #79
20230017117
2023-01-19

INFUSION SYSTEM WITH CONCURRENT TPN/INSULIN INFUSION

 #80
20220403036
2022-12-22

P-SELECTIN INHIBITOR, COMPOSITIONS THEREOF AND METHODS OF USE THEREOF

 #81
20220395516
2022-12-15

PHARMACEUTICAL COMPOSITIONS FOR CLINICAL NUTRITION

 #82
20220380361
2022-12-01

Material for the treatment of gastro-intestinal disorders

 #83
20220364117
2022-11-17

Adeno-Associated Virus Vector Delivery of Muscle Specific Micro-Dystrophin To Treat Muscular Dystrophy

 #84
20220331208
2022-10-20

Methods, compositions, and devices for supplying dietary fatty acid needs

 #85
20220331207
2022-10-20

Methods, compositions, and devices for supplying dietary fatty acid needs

 #86
20220331206
2022-10-20

Methods, compositions, and devices for supplying dietary fatty acid needs

 #87
20220313746
2022-10-06

MEDICAL-GRADE HONEY FOR GROWTH ENHANCEMENT OF INFANTS

 #88
20220313600
2022-10-06

FORMULATIONS OF PSMA IMAGING AGENTS

 #89
20220264926
2022-08-25

Devices and methods for the preparation of a nutritional formula

 #90
20220251169
2022-08-11

Activatable fusion protein and use thereof

 #91
20220233678
2022-07-28

Zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition

 #92
20220227702
2022-07-21

Method of synthesis and purification of citrulline

 #93
20220204454
2022-06-30

Crystalline salts of a plasma kallikrein inhibitor

 #94
20220202704
2022-06-30

PHARMACEUTICAL PARENTERAL COMPOSITION OF DUAL GLP1/2 AGONIST

 #95
20220177568
2022-06-09

TREATMENT OF SKIN LESIONS AND PRURITUS IN PRURIGO NODULARIS PATIENTS

 #96
20220168254
2022-06-02

PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT

 #97
20220162575
2022-05-26

Engineering of DNASE enzymes for manufacturing and therapy

 #98
20220160784
2022-05-26

METHODS AND COMPOSITIONS OF CHONDRISOMES

 #99
20220160669
2022-05-26

PARENTERAL NUTRITION FORMULATION

 #100
20220143004
2022-05-12

USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS

 #101
20220135661
2022-05-05

Monoclonal antibodies against alpha-synuclein fibrils

 #102
20220117935
2022-04-21

Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof

 #103
20220071904
2022-03-10

Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

 #104
20220054523
2022-02-24

Compounds,compositions, and methods for the treatment of disease

 #105
20220040448
2022-02-10

VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION

 #106
20220031797
2022-02-03

Pharmaceutical compositions containing hyaluronic acid and carnosine and relative use

 #107
20220008458
2022-01-13

Trace element compositions, methods of making and use

 #108
20220000766
2022-01-06

PARENTERAL NUTRITION CONTAINING TRACE ELEMENTS

 #109
20210401749
2021-12-30

Polymer particles

 #110
20210386785
2021-12-16

QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR FOR STABLE GENETIC MODIFICATION OF CELLULAR IMMUNOTHERAPIES

 #111
20210378998
2021-12-09

Parenteral nutrition formulation

 #112
20210369697
2021-12-02

Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses

 #113
20210322722
2021-10-21

VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION

 #114
20210322721
2021-10-21

VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION

 #115
20210322304
2021-10-21

STABLE READY-TO-USE CARMUSTINE PHARMACEUTICAL COMPOSITION

 #116
20210322303
2021-10-21

Lipid emulsion for parenteral nutrition comprising GPC

 #117
20210316015
2021-10-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEART DISEASE

 #118
20210308210
2021-10-07

Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growth

 #119
20210308205
2021-10-07

Method for reducing fat accumulation by using tetramethylisoscutellarein

 #120
20210301304
2021-09-30

GLUCOCEREBROSIDASE GENE THERAPY

 #121
20210300875
2021-09-30

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

 #122
20210290556
2021-09-23

METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN

 #123
20210290526
2021-09-23

LIPID EMULSION FOR PARENTERAL ADMINISTRATION

 #124
20210283229
2021-09-16

DIGESTIVE ENZYME COMPOSITION SUITABLE FOR ENTERAL ADMINISTRATION

 #125
20210261986
2021-08-26

Biological devices for producing oxidized zinc and applications thereof

 #126
20210261656
2021-08-26

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE INNER EAR DISEASE

 #127
20210261639
2021-08-26

COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT

 #128
20210260009
2021-08-26

METHODS AND COMPOSITIONS FOR THE TREATMENT OF A RENAL DISEASE

 #129
20210236468
2021-08-05

COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING A VASCULAR DISRUPTING AGENT AND TAXANE COMPOUND

 #130
20210212936
2021-07-15

PARENTERAL NUTRITION FORMULATION

 #131
20210212904
2021-07-15

Methods, compositions, and devices for supplying dietary fatty acid needs

 #132
20210207114
2021-07-08

Engineering of DNASE enzymes for manufacturing and therapy

 #133
20210169939
2021-06-10

EXTRACELLULAR VESICLES AND THEIR USES

 #134
20210162011
2021-06-03

Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes

 #135
20210128737
2021-05-06

Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

 #136
20210127728
2021-05-06

SYSTEMS AND METHODS FOR MONITORING OF FRACTIONAL GLUCONEOGENESIS AND TARGETING OF FRACTIONAL GLUCONEOGENESIS VIA NUTRITIONAL SUPPORT

 #137
20210122818
2021-04-29

HUMANIZED ANTI-BAG3 ANTIBODIES

 #138
20210121517
2021-04-29

STABLE PARENTERAL DOSAGE FORM OF CETRORELIX ACETATE

 #139
20210115449
2021-04-22

THERAPEUTIC MODULATION OF TUMOR SUPPRESSORS USING EXOSOMES

 #140
20210115428
2021-04-22

Suppression of pain by gene editing

 #141
20210100838
2021-04-08

HUMAN ANTIBODIES THAT BIND AND ARE INTERNALIZED BY MESOTHELIOMA AND OTHER CANCER CELLS

 #142
20210100751
2021-04-08

PROTECTING A BIOACTIVE AND/OR PRECURSOR THEREOF

 #143
20210100738
2021-04-08

OXYGEN DELIVERY BEVERAGE

 #144
20210100736
2021-04-08

Injectable Suspensions

 #145
20210095037
2021-04-01

METHODS FOR TREATING LATE-ONSET ASTHMA USING BENRALIZUMAB

 #146
20210093716
2021-04-01

Immunomodulating and immunostimulating ecotin polypeptides from for drug-delivery

 #147
20210093556
2021-04-01

GLUTATHIONE DISULFIDE IN PARENTERAL NUTRITION FOR MAINTAINING OR INCREASING PROTEIN SYNTHESIS

 #148
20210085641
2021-03-25

Tannin-containing gastrointestinal formulations and methods of use

 #149
20210069138
2021-03-11

Parenteral nutrition formulation with optimized amino acid and glucose content

 #150
20210059967
2021-03-04

LIQUID PARENTERAL COMPOSITIONS OF LEVOTHYROXINE

 #151
20210054027
2021-02-25

Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering

 #152
20210008123
2021-01-14

COMPOSITIONS AND METHODS OF TREATING LIVER DISEASE

 #153
20210007975
2021-01-14

Transfusion preparation

 #154
20200390798
2020-12-17

GLYCAN POLYMERS AND RELATED METHODS THEREOF

 #155
20200384064
2020-12-10

COMPOSITIONS AND METHODS USING HIGH PROTEIN FOR INDUCTION OF AUTOPHAGY

 #156
20200345648
2020-11-05

METHODS AND COMPOSITIONS FOR TREATING CANCER USING EXOSOMES-ASSOCIATED GENE EDITING

 #157
20200317625
2020-10-08

Triazoles for regulating intracellular calcium homeostasis

 #158
20200308245
2020-10-01

Analogues of PYY

 #159
20200308118
2020-10-01

Crystalline salts of a plasma kallikrein inhibitor

 #160
20200306376
2020-10-01

COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY

 #161
20200306338
2020-10-01

Antiviral peptides for treatment of the middle east respiratory syndrome

 #162
20200306316
2020-10-01

Methods and compositions relating to chondrisomes from blood products

 #163
20200306315
2020-10-01

Methods and compositions relating to chondrisomes from cultured cells

 #164
20200297638
2020-09-24

All-in-one lyophilized multivitamin emulsion for parenteral application

 #165
20200290973
2020-09-17

Farnesoid X receptor agonists and uses thereof

 #166
20200283427
2020-09-10

Muscarinic agonists as non-steroidal and non-opioid analgesics and methods of use thereof

 #167
20200282043
2020-09-10

Zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition

 #168
20200277399
2020-09-03

Cysteine engineered antigen-binding molecules

 #169
20200270641
2020-08-27

Biological devices for producing oxidized zinc and applications thereof

 #170
20200261478
2020-08-20

Fosfomycin formulation for parenteral administration

 #171
20200255420
2020-08-13

Methods for the treatment of gastro-intestinal disorders

 #172
20200247846
2020-08-06

INHIBITION OF OXIDATIVE STRESS, GLYCATION, AND PROTEIN CROSSLINKING

 #173
20200246402
2020-08-06

Pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting

 #174
20200239563
2020-07-30

Treatment of skin lesions and pruritus in prurigo nodularis patients

 #175
20200230221
2020-07-23

COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY AND USES THEREOF

 #176
20200222493
2020-07-16

Methods for administering angiotensin II

 #177
20200222448
2020-07-16

Stable, highly pure L-cysteine compositions for injection and methods of use

 #178
20200222364
2020-07-16

Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof

 #179
20200199621
2020-06-25

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MUSCLE SPECIFIC MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY

 #180
20200188381
2020-06-18

Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses

 #181
20200179518
2020-06-11

Biodegradable block copolymer drug delivery composition

 #182
20200171157
2020-06-04

Pharmaceutical composition

 #183
20200171087
2020-06-04

METHODS FOR TREATING MERKEL CELL CARCINOMA (MCC) USING NK-92 CELLS

 #184
20200163873
2020-05-28

Biodegradable block copolymer drug delivery composition

 #185
20200148768
2020-05-14

ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF

 #186
20200147178
2020-05-14

Fusion protein comprising IL-4 and IL-10

 #187
20200140389
2020-05-07

Crystalline salts of a plasma kallikrein inhibitor

 #188
20200138935
2020-05-07

CHLAMYDIA NANOEMULSION VACCINE

 #189
20200138893
2020-05-07

Method for reducing fat accumulation by using early-harvested citrus reticulata fruit extract

 #190
20200138821
2020-05-07

Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disorders

 #191
20200131222
2020-04-30

Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside

 #192
20200131142
2020-04-30

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

 #193
20200131134
2020-04-30

Farnesoid X receptor agonists and uses thereof

 #194
20200131132
2020-04-30

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

 #195
20200121765
2020-04-23

Composition comprising alkaline phosphatase for use in the treatment of arthritides

 #196
20200115690
2020-04-16

Manufacturing and engineering of DNASE enzymes for therapy

 #197
20200115460
2020-04-16

Anti-IGF-I receptor antibodies, encoding nucleic acid molecules and methods of using said antibodies

 #198
20200101111
2020-04-02

Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies

 #199
20200101030
2020-04-02

MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME

 #200
20200093863
2020-03-26

Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies

 #201
20200069780
2020-03-05

C1-esterase inhibitor preparation

 #202
20200069623
2020-03-05

Cilastatin for use in the treatment of sepsis

 #203
20200062835
2020-02-27

Monoclonal antibodies against alpha-synuclein fibrils

 #204
20200038441
2020-02-06

Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies

 #205
20200030429
2020-01-30

Immunostimulatory preparation exhibiting antitumor activity

 #206
20200022941
2020-01-23

Long-term efficacy of liver disease treatment with EPA and DHA

 #207
20200009100
2020-01-09

Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

 #208
20190388499
2019-12-26

MACROCYCLIC PEPTIDES TO DECREASE C-MYC PROTEIN LEVELS AND REDUCE CANCER CELL GROWTH

 #209
20190381109
2019-12-19

Medical-grade honey for growth enhancement of infants

 #210
20190367923
2019-12-05

Antisense oligonucleotides that inhibit influenza virus replication and uses thereof

 #211
20190350838
2019-11-21

Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof

 #212
20190345246
2019-11-14

Compositions and Methods for Treating Autoimmune Inner Ear Disease

 #213
20190338059
2019-11-07

Polymer particles

 #214
20190330655
2019-10-31

ONCOLYTIC VIRUSES AND THERAPEUTIC MOLECULES

 #215
20190314387
2019-10-17

Compositions and methods of treating liver disease

 #216
20190314307
2019-10-17

3-HYDROXYBUTYRATE ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF CRITICAL CARE TREATMENT

 #217
20190309302
2019-10-10

Antisense oligonucleotides

 #218
20190307749
2019-10-10

Mitochondria-Division Inhibitor 1 Protects Against Amyloid-B Induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease

 #219
20190300620
2019-10-03

Engineered CD46-specific effector cells and uses thereof in the treatment of cancer

 #220
20190298721
2019-10-03

STABLE PRO-VITAMIN DERIVATIVE COMPOUNDS, PHARMACEUTICAL AND DIETARY COMPOSITIONS, AND METHODS OF THEIR USE

 #221
20190292165
2019-09-26

Broad spectrum inhibitors of filoviruses

 #222
20190290675
2019-09-26

GLYCAN POLYMERS AND RELATED METHODS THEREOF

 #223
20190262372
2019-08-29

Compounds,Compositions, and methods for the treatment of disease

 #224
20190255199
2019-08-22

NON-INVASIVE DIAGNOSTIC IMAGING AGENT FOR HEART DISEASE

 #225
20190247506
2019-08-15

Stabilized preparation of interferon beta variant

 #226
20190247496
2019-08-15

VACCINE TREATMENT AND CONTROL INFECTIOUS THAN PATOLOGIAS UTILIZING HEPARAN SULFATE (HS) AS CELLULAR RECEPTOR

 #227
20190224124
2019-07-25

Methods and Kits for Reducing the Susceptibility of Lipoprotein Particles to Atherogenic Aggregation Induced by Arterial-Wall Enzymes

 #228
20190183943
2019-06-20

COMPOSITION, FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, COMPRISING STRAINS SHOWING LIPOLYSIS EFFECT

 #229
20190169256
2019-06-06

Antagonists of fish reproduction

 #230
20190153090
2019-05-23

Humanized anti-BAG3 antibodies

 #231
20190142956
2019-05-16

Compositions and methods for the inhibition of fibrosis

 #232
20190134202
2019-05-09

Liquid injectable copolymer

 #233
20190117683
2019-04-25

Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract

 #234
20190105336
2019-04-11

Phospholipid preparations for the improvement of brain plasticity

 #235
20190085326
2019-03-21

Negative feedback regulation of HIV-1 by gene editing strategy

 #236
20190076440
2019-03-14

TREATMENT OF TISSUE DISORDERS

 #237
20190075830
2019-03-14

Devices and methods for the preparation of a nutritional formula

 #238
20190071678
2019-03-07

Modulation of DYRK1B expression

 #239
20190070202
2019-03-07

Fosfomycin formulation for parenteral administration

 #240
20190062479
2019-02-28

Polymer particles

 #241
20190054098
2019-02-21

AGENTS AND METHODS USING THEREOF FOR THE PREVENTION AND TREATMENT OF STEM CELLS SENESCENCE

 #242
20190008907
2019-01-10

COMPOSITIONS FOR MANAGEMENT OF WOUNDS, SKIN DISEASES, DEHYDRATION, CHRONIC DISEASES, AND RESPIRATORY DISEASES

 #243
20190000779
2019-01-03

PHARMACEUTICAL FORMULATION

 #244
20180360094
2018-12-20

Systems and methods for monitoring of fractional gluconeogenesis and targeting of fractional gluconeogenesis via nutritional support

 #245
20180353465
2018-12-13

Tannin-containing gastrointestinal formulations and methods of use

 #246
20180303820
2018-10-25

Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers

 #247
20180303819
2018-10-25

Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses

 #248
20180280249
2018-10-04

Methods, compositions, and devices for supplying dietary fatty acid needs

 #249
20180271948
2018-09-27

Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents

 #250
20180263856
2018-09-20

Methods, compositions, and devices for supplying dietary fatty acid needs

 #251
20180228745
2018-08-16

SUBSTANCE SELECTED AMONG MIDODRINE, A PHARMACEUTICAL SALT AND AN ACTIVE METABOLITE THEREOF, FOR USE IN THE TREATMENT OF OBSTRUCTIVE CARDIOPATHY

 #252
20180221323
2018-08-09

Treatment and prevention of liver disease associated with parenteral nutrition (PN)

 #253
20180186915
2018-07-05

Polymer particles

 #254
20180169066
2018-06-21

Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof

 #255
20180103673
2018-04-19

Systems and methods for monitoring of fractional gluconeogenesis and targeting of fractional gluconeogenesis via nutritional support

 #256
20180103672
2018-04-19

Systems and methods for monitoring of fractional gluconeogenesis and targeting of fractional gluconeogenesis via nutritional support

 #257
20180094037
2018-04-05

Methods of treatment with a fusion protein comprising IL-4 and IL-10

 #258
20180050062
2018-02-22

Dialysis precursor composition product

 #259
20180027863
2018-02-01

Systems and methods for monitoring of fractional gluconeogenesis and targeting of fractional gluconeogenesis via nutritional support

 #260
20180000732
2018-01-04

EMULSIONS FOR PARENTERAL ADMINISTRATION

 #261
20170348198
2017-12-07

Methods, compositions, and devices for supplying dietary fatty acid needs

 #262
20170332686
2017-11-23

MCT-BASED NUTRITION BLEND FOR CARDIAC PROTECTION AND TREATING DEGENERATIVE MITRAL VALVE DISEASE IN COMPANION ANIMALS

 #263
20170319820
2017-11-09

Venous access catheters and methods for portal venous system catheterization

 #264
20170304530
2017-10-26

Infusion preparation

 #265
20170304248
2017-10-26

Dietary emulsion formulations and methods for using the same

 #266
20170283536
2017-10-05

Polymer particles

 #267
20170246089
2017-08-31

Methods, compositions, and devices for supplying dietary fatty acid needs

 #268
20170246088
2017-08-31

Methods, compositions, and devices for supplying dietary fatty acid needs

 #269
20170189365
2017-07-06

Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN)

 #270
20170156387
2017-06-08

CONTINUOUS MONITORING OF BLOOD GLUCOSE PRODUCTION AND ONGOING TARGETING OF BLOOD GLUCOSE PRODUCTION VIA NUTRITIONAL SUPPORT

 #271
20170151180
2017-06-01

Buprenorphine nanoparticle composition and methods thereof

 #272
20170128362
2017-05-11

APPLICATION OF LARGE-DOSE GLYCERINUM IN FREEZE-THAWING TOLERABLE LIPID EMULSION

 #273
20170056369
2017-03-02

Tannin-containing gastrointestinal formulations and methods of use

 #274
20170042837
2017-02-16

Capsule dosage form of metoprolol succinate

 #275
20170042208
2017-02-16

Systems and methods to estimate nutritional needs of human and other patients

 #276
20170027822
2017-02-02

Methods, compositions, and devices for supplying dietary fatty acid needs

 #277
20160346242
2016-12-01

Composition comprising EPA and DHA ethylester for parenteral administration

 #278
20160338987
2016-11-24

Composition comprising EPA and DHA triglycerides for parenteral administration

 #279
20160175517
2016-06-23

Infusion system with concurrent TPN/insulin infusion

 #280
20160166659
2016-06-16

Digestive enzyme composition suitable for enteral administration

 #281
20160101231
2016-04-14

Infusion preparation

 #282
20160074301
2016-03-17

Anti-aging skin care compositions and regimens

 #283
20160008286
2016-01-14

Buprenorphine nanoparticle composition and methods thereof

 #284
20150290123
2015-10-15

Enteral nutrition

 #285
20150246102
2015-09-03

Methods, compositions, and devices for supplying dietary fatty acid needs

 #286
20140225033
2014-08-14

Dialysis precursor composition

 #287
20140205673
2014-07-24

PRODUCT FOR PARENTERAL NUTRITION OF OBESE INTENSIVE-CARE PATIENTS

 #288
20140200266
2014-07-17

Tannin-containing gastrointestinal formulations and methods of use

 #289
20140120206
2014-05-01

Systems and methods to estimate nutritional needs of human and other patients

 #290
20130313261
2013-11-28

Infusion preparation

 #291
20130210715
2013-08-15

NUTRITIONAL COMPOSITIONS AND METHODS FOR WEANING FROM PARENTERAL NUTRITION TO ENTERAL NUTRITION

 #292
20130183389
2013-07-18

Dialysis precursor composition

 #293
20130096489
2013-04-18

High shear application in medical therapy

 #294
20130020226
2013-01-24

Product for parenteral nutrition of obese intensive-care patients

 #295
20110207819
2011-08-25

Fat Emulsion for Artificially Feeding Seriously Ill Intensive Care Patients

 #296
20100273735
2010-10-28

Soluble, highly branched glucose polymers for enteral and parenteral nutrition and for peritoneal dialysis

 #297
20090203626
2009-08-13

Pediatric amino acid solution for parenteral nutrition

 #298
20080275119
2008-11-06

Treatment and prevention of liver disease associated with parenteral nutrition (PN)

 #299
20070196445
2007-08-23

Method for the Prevention and Treatment of Cachexia and Anorexia

 #300
20070148259
2007-06-28

Parenteral nutrition composition containing iron